Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomePreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

TriSalus Life Sciences (TLSI) Interest & Investment Income (2022 - 2025)

TriSalus Life Sciences (TLSI) has 4 years of Interest & Investment Income data on record, last reported at $177000.0 in Q4 2025.

  • For Q4 2025, Interest & Investment Income rose 210.53% year-over-year to $177000.0; the TTM value through Dec 2025 reached $555000.0, up 37.38%, while the annual FY2025 figure was $555000.0, 37.38% up from the prior year.
  • Interest & Investment Income reached $177000.0 in Q4 2025 per TLSI's latest filing, up from $170000.0 in the prior quarter.
  • Across five years, Interest & Investment Income topped out at $314714.0 in Q2 2022 and bottomed at -$240914.0 in Q4 2022.
  • Average Interest & Investment Income over 4 years is $98125.0, with a median of $94500.0 recorded in 2024.
  • Peak YoY movement for Interest & Investment Income: plummeted 88.56% in 2023, then skyrocketed 210.53% in 2025.
  • A 4-year view of Interest & Investment Income shows it stood at -$240914.0 in 2022, then surged by 201.28% to $244000.0 in 2023, then tumbled by 76.64% to $57000.0 in 2024, then surged by 210.53% to $177000.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Interest & Investment Income were $177000.0 in Q4 2025, $170000.0 in Q3 2025, and $134000.0 in Q2 2025.